The National Children’s Medical Center is currently enrolling for the largest global clinical research program in Autism, Asperger Syndrome andÂ Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The research program, called ConnectMe, is for children ages 6 to 12.
TheÂ U.S. CentersÂ for Disease Control and Prevention estimate thatÂ one in 88 childrenÂ in the U.S. are affected by one of the aforementioned conditions.
The part of the program that is currently enrolling participants inÂ theÂ DC and Rockville areas will evaluateÂ the safety, tolerability and efficacy of the investigational drug, memantine, on social interaction and communication.
Currently, there are there are noÂ FDA-approved drugsÂ that treat any of the three core symptoms of autism, including impaired social interactions, impaired communication and restricted interests, repetitive behaviors and stereotyped mannerisms.
ConnectMe, sponsored by Forest Research Institute, Inc., is being led locally byÂ Adelaide S. Robb, MD, principal investigator,Â Childrenâ€™sÂ NationalÂ Medical Center,Â Children’s Research Institute (CRI) and her team at the CRI.
For more information, visitÂ www.connectmetrial.com.